Henry E. Pelish, Chief Scientific Officer at Nuvalent, Inc. (NUVL), sold 35,104 shares at $97.79 ($3.4M) on 2026-03-12, disclosed to the SEC on 2026-03-16.
Open-market sale of $3.4M NUVL by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $97.79 | 24,189 | $2.4M | 68.7% |
| 2 | $98.44 | 5,505 | $542K | 15.7% |
| 3 | $99.12 | 306 | $30K | 0.9% |
| 4 | $97.89 | 804 | $79K | 2.3% |
| 5 | $98.83 | 2,597 | $257K | 7.5% |
| 6 | $99.71 | 1,703 |
| $170K |
| 4.9% |
| Total | $98.08 avg | 35,104 | $3.4M | 100% |
| Filing → |
| NUVL | SELL | 2026-01-07 | $502K | — | Filing → |
| NUVL | SELL | 2025-10-17 | $2.6M | — | Filing → |
| NUVL | SELL | 2025-10-15 | $1.8M | — | Filing → |